MY148277A - Treatment of cartilage disorders with fgf-18 - Google Patents

Treatment of cartilage disorders with fgf-18

Info

Publication number
MY148277A
MY148277A MYPI20090702A MYPI20090702A MY148277A MY 148277 A MY148277 A MY 148277A MY PI20090702 A MYPI20090702 A MY PI20090702A MY PI20090702 A MYPI20090702 A MY PI20090702A MY 148277 A MY148277 A MY 148277A
Authority
MY
Malaysia
Prior art keywords
treatment
fgf
osteoarthritis
cartilage disorders
cartilage disorder
Prior art date
Application number
MYPI20090702A
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MY148277A publication Critical patent/MY148277A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THIS INVENTION CONCERNS THE TREATMENT OF CARTILAGE DISORDER AND OSTEOARTHRITIS IN PARTICULAR. MORE SPECIFICALLY, IT RELATES TO THE USE OF FGF-18 IN TREATMENT REGIMENS AND FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PATIENTS HAVING A CARTILAGE DISORDER SUCH AS OSTEOARTHRITIS, SUCH AS FOR EXAMPLE KNEE OSTEOARTHRITIS OR SECONDARY HIP OSTEOARTHRITIS. SPECIFICALLY PROVIDED IS A PREFERRED TREATMENT SCHEME COMPRISING ONCE WEEKLY ADMINISTRATION OF AN FGF-18 COMPOUND PER TREATMENT CYCLE.
MYPI20090702A 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18 MY148277A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28

Publications (1)

Publication Number Publication Date
MY148277A true MY148277A (en) 2013-03-29

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20090702A MY148277A (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (en)
BR (1) BRPI0715728A8 (en)
DK (1) DK2054050T3 (en)
ES (1) ES2392883T3 (en)
MY (1) MY148277A (en)
NZ (1) NZ574216A (en)
PT (1) PT2054050E (en)
RS (1) RS52710B (en)
SI (1) SI2054050T1 (en)
UA (1) UA99818C2 (en)
ZA (1) ZA200900426B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660818T3 (en) * 2012-08-06 2018-03-26 Merck Patent Gmbh Genetic markers to predict the responsiveness to a compound of FGF-18
SI3107559T1 (en) * 2014-02-20 2018-11-30 Merck Patent Gmbh Fgf-18 compound dosing regimen
CN106232153B (en) * 2014-02-20 2020-01-17 默克专利有限公司 FGF-18 for transplantation and tissue engineering surgery
PT3107592T (en) * 2014-02-20 2018-12-03 Merck Patent Gmbh Implant comprising fgf-18
CN107405388A (en) * 2015-01-08 2017-11-28 衣阿华大学研究基金会 Method for internal Regeneration of Articular Cartilage
EP3322736B1 (en) 2015-07-15 2021-09-01 Prosit Sole Biotechnology (Beijing) Co., Ltd Fusion polypeptides and methods of use
AU2016306626A1 (en) * 2015-08-13 2018-02-22 Merck Patent Gmbh Combination composition comprising FGF-18 compound
JP2023502520A (en) * 2019-11-21 2023-01-24 リミディアム バイオ，インコーポレーテッド growth factor recovery
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (en) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 mRNA for treating osteoarthritis and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003279835B2 (en) * 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
EP2327413A1 (en) * 2004-07-06 2011-06-01 ZymoGenetics, Inc. Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
PT1828239E (en) * 2004-12-10 2011-10-27 Zymogenetics Inc Fgf18 production in prokaryotic hosts

Also Published As

Publication number Publication date
UA99818C2 (en) 2012-10-10
ZA200900426B (en) 2010-04-28
CN101505787A (en) 2009-08-12
PT2054050E (en) 2012-09-17
DK2054050T3 (en) 2012-09-03
BRPI0715728A2 (en) 2013-09-17
BRPI0715728A8 (en) 2018-04-03
CN101505787B (en) 2013-09-04
SI2054050T1 (en) 2012-12-31
RS52710B (en) 2013-08-30
ES2392883T3 (en) 2012-12-14
NZ574216A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
WO2008023063A3 (en) Treatment of cartilage disorders with fgf-18
MY148277A (en) Treatment of cartilage disorders with fgf-18
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
TW200716672A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
MX337575B (en) Sulphone compounds for use in the treatment of obesity.
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
MY162067A (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
TW200734334A (en) Treatment of substance abuse
UA85471C2 (en) Use of oxycodone for treating visceral pain
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
NZ597419A (en) Formulations for the treatment of deep tissue pain
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
MX2012007813A (en) Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent.
WO2007134326A3 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
MX2009003532A (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin.
EA201070193A1 (en) TREATMENT OF CHILDREN'S TUMORS
IL198202A0 (en) Peptide-cytotoxic conjugates
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
MX2008013477A (en) Bicyclic tetrahydropyrrole compounds.
WO2010072774A3 (en) 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal
MX2009011214A (en) Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin -4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas.